Despite the widespread popularity of new weight-loss medications, research suggests a non-drug alternative is significantly ...

For the last installment of the America in Focus project this year, we spoke with 14 Americans from all walks of life who are ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Brace yourselves, Ozempic and Zepound. Eli Lilly just released a jaw-dropping sneak peek from the final phases of testing for ...